| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 |
Disc Medicine Inc
IRON
|
BUY |
$86.00
Est. +28%
|
$67.30 | $72.07 |
Pending
|
$66.44
-1.3%
|
| Aug 26, 2026 |
Argen X SE - ADR
ARGX
|
BUY |
$1,415.00
Est. +39%
|
$1,019.49 | $1,072.75 |
Pending
|
$959.49
-5.9%
|
| Aug 14, 2026 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$256.00
Est. +13%
|
$227.12 | $272.00 |
Target Met
|
$255.96
+12.7%
|
| Aug 11, 2026 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$102.00
Est. +20%
|
$84.67 | $89.49 |
Pending
|
$65.57
-22.6%
|
| Jul 13, 2026 |
Q32 Bio Inc.
QTTB
|
BUY |
$66.00
Est. +225%
|
$20.29 | $23.57 |
Pending
|
$9.22
-54.6%
|
| Jun 29, 2026 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$31.00
Est. +67%
|
$18.58 | $24.80 |
Pending
|
$20.47
+10.2%
|
| May 13, 2026 |
Celldex Therapeutics Inc.
CLDX
|
BUY |
$54.00
Est. +69%
|
$32.00 | $45.14 |
Pending
|
$31.10
-2.8%
|
| Jan 29, 2026 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$29.00
Est. +62%
|
$17.87 | $27.50 |
Pending
|
$23.01
+28.8%
|
| Jan 20, 2026 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$330.00
Est. +60%
|
$205.83 | $281.79 |
Pending
|
$225.60
+9.6%
|
| Jan 20, 2026 |
Soleno Therapeutics Inc
SLNO
|
BUY |
$114.00
Est. +168%
|
$42.48 | $53.01 |
Pending
|
$53.01
+24.8%
|
| Jan 20, 2026 |
Rhythm Pharmaceuticals Inc.
RYTM
|
BUY |
$145.00
Est. +43%
|
$101.63 | $119.75 |
Pending
|
$98.66
-2.9%
|
| Jan 06, 2026 |
Alumis Inc.
ALMS
|
BUY |
$39.00
Est. +130%
|
$16.97 | $31.35 |
Pending
|
$7.29
-57.0%
|
| Dec 09, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$116.00
Est. +23%
|
$94.30 | $130.05 |
Target Met
|
$111.95
+18.7%
|
| Dec 08, 2025 |
Incyte Corp.
INCY
|
BUY |
$116.00
Est. +13%
|
$102.52 | $132.58 |
Target Met
|
$123.89
+20.8%
|
| Nov 14, 2025 |
Septerna, Inc.
SEPN
|
BUY |
$28.00
Est. +46%
|
$19.24 | $51.09 |
Target Met
|
$38.13
+98.2%
|
| Nov 05, 2025 |
Soleno Therapeutics Inc
SLNO
|
BUY |
$106.00
Est. +66%
|
$63.85 | $55.47 |
Pending
|
$53.01
-17.0%
|
| Oct 29, 2025 |
Incyte Corp.
INCY
|
BUY |
$97.00
Est. +5%
|
$92.02 | $132.58 |
Target Met
|
$123.89
+34.6%
|
| Oct 21, 2025 |
Exelixis Inc
EXEL
|
SELL |
$30.00
Est. +13%
|
$34.54 | $34.64 (Low) |
Pending
|
$58.16
-68.4%
|
| Sep 23, 2025 |
C4 Therapeutics Inc
CCCC
|
BUY |
$10.00
Est. +257%
|
$2.80 | $5.17 |
Miss
|
$2.98
+6.4%
|
| Sep 15, 2025 |
Atyr Pharma Inc
ATYR
|
SELL |
$1.00
Est. +2%
|
$1.02 | $0.38 (Low) |
Target Met
|
$0.34
+66.9%
|
| May 16, 2025 |
Septerna, Inc.
SEPN
|
BUY |
$18.00
Est. +83%
|
$9.84 | $32.63 |
Target Met
|
$38.13
+287.5%
|
| Mar 12, 2025 |
Arvinas Inc
ARVN
|
BUY |
$26.00
Est. +213%
|
$8.30 | $16.14 |
Miss
|
$7.59
-8.6%
|
| Feb 18, 2025 |
Septerna, Inc.
SEPN
|
BUY |
$14.00
Est. +8%
|
$12.96 | $31.34 |
Target Met
|
$38.13
+194.2%
|
| Dec 19, 2024 |
Kezar Life Sciences Inc
KZR
|
BUY |
$9.00
Est. +44%
|
$6.26 | $6.95 |
Miss
|
$7.29
+16.5%
|
| Dec 19, 2024 |
C4 Therapeutics Inc
CCCC
|
BUY |
$12.00
Est. +178%
|
$4.31 | $4.26 |
Miss
|
$2.98
-30.9%
|
| Dec 02, 2024 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$57.00
Est. +17%
|
$48.54 | $68.80 |
Target Met
|
$111.95
+130.6%
|
| Nov 01, 2024 |
Zymeworks BC Inc
ZYME
|
SELL |
$12.00
Est. +10%
|
$13.28 | $9.04 (Low) |
Target Met
|
$26.52
-99.7%
|
| Oct 16, 2024 |
Acelyrin Inc
SLRN
|
BUY |
$15.00
Est. +162%
|
$5.72 | $6.52 |
Miss
|
$2.27
-60.3%
|
| Oct 15, 2024 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$32.00
Est. +27%
|
$25.16 | $29.56 |
Miss
|
$23.01
-8.5%
|
| Sep 25, 2024 |
Celldex Therapeutics Inc.
CLDX
|
BUY |
$44.00
Est. +22%
|
$36.02 | $47.00 |
Target Met
|
$31.10
-13.7%
|
| Sep 17, 2024 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$289.00
Est. +107%
|
$139.57 | $208.16 |
Miss
|
$225.60
+61.6%
|
| Sep 11, 2024 |
Q32 Bio Inc.
QTTB
|
BUY |
$95.00
Est. +88%
|
$50.61 | $53.73 |
Miss
|
$9.22
-81.8%
|
| Jun 24, 2024 |
Argen X SE - ADR
ARGX
|
BUY |
$542.00
Est. +37%
|
$394.47 | $678.21 |
Target Met
|
$959.49
+143.2%
|
| Jun 05, 2024 |
Annexon Inc
ANNX
|
BUY |
$14.00
Est. +134%
|
$5.99 | $7.85 |
Miss
|
$3.64
-39.2%
|
| May 23, 2024 |
Apellis Pharmaceuticals Inc
APLS
|
BUY |
$48.00
Est. +10%
|
$43.60 | $42.47 |
Miss
|
$41.03
-5.9%
|
| May 15, 2024 |
Annexon Inc
ANNX
|
BUY |
$10.00
Est. +107%
|
$4.82 | $7.85 |
Miss
|
$3.64
-24.5%
|
| Apr 01, 2024 |
Annexon Inc
ANNX
|
BUY |
$12.00
Est. +67%
|
$7.17 | $7.85 |
Miss
|
$3.64
-49.2%
|
| Mar 20, 2024 |
Acelyrin Inc
SLRN
|
BUY |
$13.00
Est. +56%
|
$8.32 | $7.25 |
Miss
|
$2.27
-72.7%
|
| Mar 12, 2024 |
Ventyx Biosciences Inc
VTYX
|
BUY |
$16.00
Est. +90%
|
$8.42 | $3.39 |
Miss
|
$14.00
+66.3%
|
| Dec 19, 2023 |
Arvinas Inc
ARVN
|
BUY |
$63.00
Est. +66%
|
$37.87 | $34.09 |
Miss
|
$7.59
-80.0%
|
| Nov 10, 2023 |
Celldex Therapeutics Inc.
CLDX
|
BUY |
$27.00
Est. +5%
|
$25.78 | $47.00 |
Target Met
|
$31.10
+20.6%
|
| Jan 02, 2023 |
Apellis Pharmaceuticals Inc
APLS
|
BUY |
$58.00
Est. +12%
|
$51.71 | - | - |
$41.03
-20.7%
|
| Aug 17, 2022 |
Blueprint Medicines Corp
BPMC
|
SELL |
$41.00
Est. +22%
|
$52.78 | - | - |
$129.46
-145.3%
|
| May 31, 2022 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$25.00
Est. +148%
|
$10.09 | - | - |
$23.01
+128.0%
|
| Feb 09, 2022 |
Arvinas Inc
ARVN
|
BUY |
$98.00
Est. +31%
|
$74.68 | - | - |
$7.59
-89.8%
|
| Dec 06, 2021 |
Canopy Growth Corporation
CGC
|
SELL |
$8.00
Est. +21%
|
$10.15 | - | - |
$0.94
+90.7%
|
| May 09, 2021 |
Galapagos NV - ADR
GLPG
|
BUY |
$97.00
Est. +32%
|
$73.54 | - | - |
$27.98
-62.0%
|
| May 06, 2021 |
Madrigal Pharmaceuticals Inc
MDGL
|
BUY |
$130.00
Est. +3%
|
$126.71 | - | - |
$516.56
+307.7%
|
| May 06, 2021 |
Intercept Pharmaceuticals Inc
ICPT
|
SELL |
$16.00
Est. +6%
|
$17.01 | - | - |
$19.00
-11.7%
|
| May 04, 2021 |
Esperion Therapeutics Inc.
ESPR
|
SELL |
$20.00
Est. +22%
|
$25.59 | - | - |
$3.18
+87.6%
|